Display options
Cite
Cook IT, Leyh TS, Kadlubar SA, et al. Structural rearrangement of SULT2A1: effects on dehydroepiandrosterone and raloxifene sulfation. Horm Mol Biol Clin Investig. 2010;1(2):81-87doi: 10.1515/HMBCI.2010.012.
Cook, I. T., Leyh, T. S., Kadlubar, S. A., & Falany, C. N. (2010). Structural rearrangement of SULT2A1: effects on dehydroepiandrosterone and raloxifene sulfation. Hormone molecular biology and clinical investigation, 1(2), 81-87. https://doi.org/10.1515/HMBCI.2010.012
Cook, Ian T, et al. "Structural rearrangement of SULT2A1: effects on dehydroepiandrosterone and raloxifene sulfation." Hormone molecular biology and clinical investigation vol. 1,2 (2010): 81-87. doi: https://doi.org/10.1515/HMBCI.2010.012
Cook IT, Leyh TS, Kadlubar SA, Falany CN. Structural rearrangement of SULT2A1: effects on dehydroepiandrosterone and raloxifene sulfation. Horm Mol Biol Clin Investig. 2010;1(2):81-87. doi: 10.1515/HMBCI.2010.012. PMID: 21822452; PMCID: PMC3149901.
Copy Download .nbib Format: NLM
Share it on

Horm Mol Biol Clin Investig. 2010;1(2):81-87. doi: 10.1515/HMBCI.2010.012.

Structural rearrangement of SULT2A1: effects on dehydroepiandrosterone and raloxifene sulfation.

Hormone molecular biology and clinical investigation

Ian T Cook, Thomas S Leyh, Susan A Kadlubar, Charles N Falany

Affiliations

  1. Department of Pharmacology and Toxicology, University of Alabama at Birmingham, Birmingham, AL, USA.

PMID: 21822452 PMCID: PMC3149901 DOI: 10.1515/HMBCI.2010.012

Abstract

BACKGROUND: Human cytosoloic sulfotransferase (SULT) 2A1 is a major hepatic isoform and sulfates hydroxyl groups in structurally diverse sterols and xenobiotics. SULT2A1 crystal structures resolved in the presence and absence of 3',5'-diphosphoadenosine (PAP) or dehydropeiandrosterone (DHEA) suggest a significant rearrangement of the peptide that forms the surface of the active site in the presence of PAP. MATERIALS AND METHODS: Molecular modeling was used to examine the effects of the rearrangement in SULT2A1 associated with 3'-phosphoadenosine 5'-phosphosulfate (PAPS) binding on the binding of DHEA and raloxifene. The kinetics of DHEA and raloxifene sulfation was analyzed to investigate the effects of the rearrangement on SULT2A1 activity. RESULTS: Molecular models indicate that DHEA is able to bind to SULT2A1 in both conformations (open, without PAP; closed, with PAP) in a catalytic configuration, whereas raloxifene bound in a catalytic conformation only in the open structure. Raloxifene did not bind in the smaller, closed substrate binding pocket. Kinetic analysis of DHEA sulfation was consistent with a random Bi-Bi reaction mechanism, whereas raloxifene sulfation was more indicative of an ordered reaction mechanism with raloxifene binding first. Initial burst kinetics with DHEA yielded similar results after preincubation of SULT2A1 with DHEA or PAPS. Preincubation of SULT2A1 with raloxifene showed a burst of raloxifene sulfate formation with the addition of PAPS. In contrast, little raloxifene sulfate was formed if SULT2A1 was preincubated with PAPS and the reaction initiated with raloxifene. CONCLUSIONS: The structural rearrangements in SULT2A1 caused by PAPS binding can alter the sulfation mechanism and kinetics of different substrates.

References

  1. Arch Biochem Biophys. 2001 Jun 15;390(2):149-57 - PubMed
  2. FEBS Lett. 2000 Jun 9;475(1):61-4 - PubMed
  3. J Chem Inf Model. 2005 Mar-Apr;45(2):215-21 - PubMed
  4. FASEB J. 1997 Mar;11(4):206-16 - PubMed
  5. J Biol Chem. 2003 Feb 28;278(9):7655-62 - PubMed
  6. J Biol Chem. 2004 Jan 23;279(4):2689-96 - PubMed
  7. Biochem J. 1989 Jun 15;260(3):641-6 - PubMed
  8. Mol Pharmacol. 2008 Mar;73(3):660-8 - PubMed
  9. Biochemistry. 2008 Nov 11;47(45):11894-9 - PubMed
  10. J Lipid Res. 1986 Nov;27(11):1111-23 - PubMed
  11. Biochem J. 1993 Jan 1;289 ( Pt 1):233-40 - PubMed
  12. J Mol Biol. 2001 Apr 27;308(2):377-95 - PubMed
  13. Proteins. 2006 Sep 1;64(4):1091-4 - PubMed
  14. J Chem Inf Comput Sci. 2003 Mar-Apr;43(2):629-36 - PubMed
  15. Biochem J. 2002 May 15;364(Pt 1):165-71 - PubMed
  16. Protein Sci. 2003 Sep;12(9):2001-14 - PubMed
  17. J Biol Chem. 2003 Nov 7;278(45):44593-9 - PubMed
  18. J Mol Biol. 1997 Apr 18;267(5):1268-82 - PubMed
  19. J Steroid Biochem Mol Biol. 1994 Mar;48(4):369-75 - PubMed
  20. Drug Metab Dispos. 2006 Mar;34(3):361-8 - PubMed
  21. J Chem Inf Comput Sci. 2000 Mar-Apr;40(2):495-502 - PubMed
  22. Biochem J. 1990 Dec 15;272(3):597-604 - PubMed
  23. J Biol Chem. 1998 May 1;273(18):10888-92 - PubMed
  24. J Biol Chem. 1981 Nov 10;256(21):11123-7 - PubMed
  25. Ann N Y Acad Sci. 1995 Dec 29;774:59-72 - PubMed
  26. PLoS Biol. 2007 May;5(5):e97 - PubMed
  27. J Mol Graph Model. 2002 Dec;21(3):161-70 - PubMed
  28. J Chem Inf Comput Sci. 2001 Mar-Apr;41(2):446-50 - PubMed
  29. J Steroid Biochem Mol Biol. 2007 Nov-Dec;107(3-5):202-10 - PubMed

Publication Types

Grant support